Two executives with Pfizer Inc. sold millions of dollars worth of shares in the company on Monday, a day when the drug company announced positive news about a promising vaccine for COVID-19 that sent the shares sharply higher. CEO Albert Bourla sold 132,508 shares in the drug company he runs, for an average selling price of $41.94 apiece. Monday was the day the company announced promising results about its potential COVID-19 vaccine, news that sent the stock rising as much as 15 per cent. Bourla still owns 81,812 shares in the company — a stake worth about $3.5 million. Susman still owns 108,804 shares in the company, a stake worth about $4 million US at current prices.

Source: CBC News November 11, 2020 14:34 UTC